JVI Accepts, published online ahead of print on 7 November 2007
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoenly, K. A.
Right arrow Articles by Weiner, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoenly, K. A.
Right arrow Articles by Weiner, D. B.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01634-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

HIV-1 Vaccine Development: Recent Advances in the CTL Platform "Spotty Business"

Kimberly A. Schoenly and David B. Weiner*

The Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine

* To whom correspondence should be addressed. Email: dbweiner{at}mail.med.upenn.edu.


arrow
Abstract

For human immunodeficiency virus type 1 (HIV-1) vaccine development, a central focus is to develop a vaccine that drives primarily strong and broad CD8+ cytotoxic T lymphocytes (CTLs). ...




This article has been cited by other articles:

  • Morrow, M. P., Pankhong, P., Laddy, D. J., Schoenly, K. A., Yan, J., Cisper, N., Weiner, D. B. (2009). Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood 113: 5868-5877 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»